Molecular cloning and expression of human EP3 receptors: evidence of three variants with differing carboxyl termini

British Journal of Pharmacology

Volumn 112, Issue 2, 1994, Pages 377-385

  Regan, J W ^c   Bailey, T J ^a   Donello, J E ^a,b   Pierce, K L ^a   Pepperl, D J ^a   Zhang, D ^a   Kedzie, K M ^a,b   Fairbairn, C E ^a,b   Bogardus, A M ^a,b   Woodward, D F ^a,b   Gil, D W ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b ALLERGAN INC   (United States)

^c NONE

Author keywords

adenylyl cyclase; CAT assays; cDNA; cyclic AMP inhibition; G protein coupled; Prostaglandin; small intestine

Indexed keywords

11 DEOXY 16 PHENOXY 17,18,19,20 TETRANORPROSTAGLANDIN E1; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 [4 (1 HYDROXYHEXYL)PHENYL] 5 OXOCYCLOPENTANEHEPTANOIC ACID; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; ADENYLATE CYCLASE; CYCLIC AMP; DNA; MESSENGER RNA; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR; PROSTANOID RECEPTOR; RECEPTOR SUBTYPE; SULPROSTONE; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SMALL INTESTINE;

ADENYLATE CYCLASE; ALPROSTADIL; AMINO ACID SEQUENCE; ANIMAL; BASE SEQUENCE; BLOTTING, NORTHERN; CLONING, MOLECULAR; HUMAN; MICE; MOLECULAR SEQUENCE DATA; PLASMIDS; POLYMERASE CHAIN REACTION; RADIOLIGAND ASSAY; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION, GENETIC;

EID: 0028356164     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1994.tb13082.x     Document Type: Article

References (31)

1. Prostanoid receptors in smooth muscle: further evidence for a proposed classification
2. 2‐sensitive (EP‐) receptors
3. Use of eukaryotic expression technology in the functional analysis of cloned genes
4. 2 receptor: two molecular forms generated by alternative splicing
5. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation
6. The classification of prostaglandin DP‐receptors in platelets and vasculature using BWA868C, a novel, selective and potent competitive antagonist
7. 2 dopamine receptor isoforms
8. 3 dopamine receptor produced through various patterns of alternative splicing
9. 2 receptor
10. 2 subtype
11. Functional responses of cloned muscarinic receptors expressed in CHO‐K1 cells
12. G protein‐coupled receptor kinases
13. 2‐C10 homolog responsible for an interspecies variation in antagonist binding
14. 2 receptors: evidence for different subclasses in the rat
15. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues
16. Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC
17. 2 dopamine receptors produced by alternative RNA splicing
18. Alternative splicing of C‐terminal tail of prostaglandin E receptor subtype EP3 determines G‐protein specificity
19. 3 subtype: Different COOH‐terminal domains determine sensitivity to agonist‐induced desensitization
20. 1B receptors
21. 2‐adrenergic receptor subtypes to cAMP‐dependent reporter gene expression in transiently transfected JEG‐3 cells
22. 2‐adrenergic receptor subtype
23. A prostaglandin E receptor coupled to a pertussis toxin‐sensitive guanine nucleotide regulatory protein in rabbit cortical collecting tubule cells
24. i proteins
25. 3 Subtype
26. 3 subtype
27. 2‐adrenergic receptor in agonist‐induced down‐regulation of the receptor
28. 2 receptors form canine renal medulla: evidence for physical association of the receptor protein with the inhibitory guanine nucleotide‐binding protein
29. Identification of the FP‐receptor as a discrete entity by radioligand binding in biosystems that exhibit different functional rank orders of potency to prostanoids
30. Further studies on ocular responses to DP receptor stimulation